title: CD4+ T cells regulate surgical and postinfectious adhesion formation.
abstract: The development of adhesions in the peritoneal and pelvic cavities, which commonly form after surgery or infection, cause significant morbidity and mortality. However, the pathogenesis of adhesion formation is still poorly understood. Because T cells are important in orchestrating fibrinogenic tissue disorders, we hypothesized that they play a critical role in the pathogenesis of peritoneal adhesion formation. Using a cecal abrasion surgical model in rodents, T cell depletion and adoptive transfer experiments demonstrated that this host response is dependent on CD4+ alphabeta T cells. These cells were also critical to adhesion formation associated with experimental intraabdominal sepsis. T cell transfer studies with mice deficient in signal transducer and activator of transcription (Stat)4 and Stat6 revealed that adhesion formation was dependent on a T helper 1 response. Activated T cells homed to the peritoneal cavity 6 hours after cecal abrasion surgery and predominated at this site during adhesiogenesis. Increased levels of the T cell-derived proinflammatory cytokine interleukin (IL)-17 and of neutrophil chemoattractant CXC chemokines macrophage inflammatory protein-2/CXCL8 and cytokine-induced neutrophil chemoattractant/CXCL1 were associated with adhesion formation. The production of these chemokines was dependent on T cells. Furthermore, the administration of neutralizing antibodies specific for IL-17 or the receptor that binds these CXC chemokines, CXC chemokine receptor 2, significantly reduced the degree of adhesion formation. These results demonstrate for the first time that the immunopathogenesis of adhesion formation is under the control of T cells and that T cell-derived cytokines and chemokines play important roles in the development of this deleterious host response.
authors.affiliation: Channing Laboratory, Department of Medicine, 181 Longwood Avenue, Boston, MA 02115, USA.
authors.forename: Doo Ryeon
authors.initials: DR
authors.lastname: Chung
authors.forename: Tanuja
authors.initials: T
authors.lastname: Chitnis
authors.forename: Ronald J
authors.initials: RJ
authors.lastname: Panzo
authors.forename: Dennis L
authors.initials: DL
authors.lastname: Kasper
authors.forename: Mohamed H
authors.initials: MH
authors.lastname: Sayegh
authors.forename: Arthur O
authors.initials: AO
authors.lastname: Tzianabos
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000502:physiology / Q000637:transplantation; D002432:Cecum / Q000276:immunology / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D019743:Chemokines, CXC / Q000378:metabolism; D005434:Flow Cytometry; D020381:Interleukin-17 / Q000037:antagonists & inhibitors / Q000378:metabolism; D007700:Kinetics; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D011917:Rats, Inbred Lew; D023063:Receptors, Interleukin-8B / Q000037:antagonists & inhibitors / Q000378:metabolism; D018805:Sepsis / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D018417:Th1 Cells / Q000276:immunology / Q000637:transplantation; D000267:Tissue Adhesions / Q000276:immunology / Q000378:metabolism / Q000473:pathology*
chemical_list: D019743:Chemokines, CXC; D020381:Interleukin-17; D023063:Receptors, Interleukin-8B